Multiple Assemblies exist for SMTL entry 4qev
Crystal structure of BRD2(BD2) mutant with ligand ME bound (METHYL (2R)- 2-[(4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4H-[1,2,4]TRIAZOLO[4,3-A][1, 4]BENZODIAZEPIN-4-YL]PROPANOATE); X-RAY DIFFRACTION 1.80 Å

	SMTL ID 4qev.1 Ligands methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]propanoate; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL Polypeptides Bromodomain-containing protein 2 Oligo-state monomer
	SMTL ID 4qev.2 Ligands methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]propanoate; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL Polypeptides Bromodomain-containing protein 2 Oligo-state homo-dimer
	SMTL ID 4qev.3 Ligands methyl (2R)-2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]propanoate; NONAETHYLENE GLYCOL; NICKEL (II) ION; GLYCEROL Polypeptides Bromodomain-containing protein 2 Oligo-state homo-dimer